Benefit of Combined Resynchronization and Defibrillator Therapy in Heart Failure Patients With and Without Ventricular Arrhythmias

Journal of the American College of Cardiology

Volumn 48, Issue 3, 2006, Pages 464-470

  Ypenburg, Claudia ^a   van Erven, Lieselot ^a   Bleeker, Gabe B ^a   Bax, Jeroen J ^a   Bootsma, Marianne ^a   Wijffels, Maurits C ^a   van der Wall, Ernst E ^a   Schalij, Martin J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; DEFIBRILLATION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION; PRIMARY PREVENTION; PRIORITY JOURNAL; QRS COMPLEX; QUALITY OF LIFE; QUESTIONNAIRE; SECONDARY PREVENTION; TREATMENT OUTCOME;

AGED; ARRHYTHMIA; CARDIAC OUTPUT, LOW; CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; STROKE VOLUME; SURVIVAL ANALYSIS; UNNECESSARY PROCEDURES;

EID: 33746200170     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.04.072     Document Type: Article

References (33)

1. Levy D., Kenchaiah S., Larson M.G., et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347 (2002) 1397-1402
2. Khand A., Gemmel I., Clark A.L., and Cleland J.G. Is the prognosis of heart failure improving?. J Am Coll Cardiol 36 (2000) 2284-2286
3. Abraham W.T., Fisher W.G., Smith A.L., et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 346 (2002) 1845-1853
4. Auricchio A., Stellbrink C., Sack S., et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 39 (2002) 2026-2033
5. Gras D., Leclercq C., Tang A.S., Bucknall C., Luttikhuis H.O., and Kirstein-Pedersen A. Cardiac resynchronization therapy in advanced heart failure. the multicenter InSync clinical study. Eur J Heart Fail 4 (2002) 311-320
6. Linde C., Leclercq C., Rex S., et al. Long-term benefits of biventricular pacing in congestive heart failure. results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 40 (2002) 111-118
7. Young J.B., Abraham W.T., Smith A.L., et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure. the MIRACLE ICD trial. JAMA 289 (2003) 2685-2694
8. Cleland J.G., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
9. Ezekowitz J.A., Armstrong P.W., and McAlister F.A. Implantable cardioverter defibrillators in primary and secondary prevention. a systematic review of randomized, controlled trials. Ann Intern Med 138 (2003) 445-452
10. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
11. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
12. Gregoratos G., Cheitlin M.D., Conill A., et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (Committee on Pacemaker Implantation). J Am Coll Cardiol 31 (1998) 1175-1209
13. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
14. Rector T.S., Kubo S.H., and Cohn J.N. Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol 71 (1993) 1106-1107
15. Lipkin D.P., Scriven A.J., Crake T., and Poole-Wilson P.A. Six minute walking test for assessing exercise capacity in chronic heart failure. Br Med J (Clin Res Ed) 292 (1986) 653-655
16. Schiller N.B., Shah P.M., Crawford M., et al., American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 2 (1989) 358-367
17. Moss A.J. MADIT-II. substudies and their implications. Card Electrophysiol Rev 7 (2003) 430-433
18. Wilkoff B.L., Hess M., Young J., and Abraham W.T. Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients. J Cardiovasc Electrophysiol 15 (2004) 1002-1009
19. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337 (1997) 1576-1583
20. Backenkohler U., Erdogan A., Steen-Mueller M.K., et al. Long-term incidence of malignant ventricular arrhythmia and shock therapy in patients with primary defibrillator implantation does not differ from event rates in patients treated for survived cardiac arrest. J Cardiovasc Electrophysiol 16 (2005) 478-482
21. Bansch D., Antz M., Boczor S., et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy. the Cardiomyopathy Trial (CAT). Circulation 105 (2002) 1453-1458
22. Trappe H.J., Wenzlaff P., Pfitzner P., and Fieguth H.G. Long-term follow up of patients with implantable cardioverter-defibrillators and mild, moderate, or severe impairment of left ventricular function. Heart 78 (1997) 243-249
23. Sweeney M.O., Wathen M.S., Volosin K., et al. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients. results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial. Circulation 111 (2005) 2898-2905
24. Higgins S.L., Yong P., Sheck D., et al., Ventak CHF Investigators. Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy. J Am Coll Cardiol 36 (2000) 824-827
25. Zagrodzky J.D., Ramaswamy K., Page R.L., et al. Biventricular pacing decreases the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy. Am J Cardiol 87 (2001) 1208-1210
26. Walker S., Levy T.M., Rex S., et al. Usefulness of suppression of ventricular arrhythmia by biventricular pacing in severe congestive cardiac failure. Am J Cardiol 86 (2000) 231-233
27. Kies P., Bax J.J., Molhoek S.G., et al. Effect of left ventricular remodeling after cardiac resynchronization therapy on frequency of ventricular arrhythmias. Am J Cardiol 94 (2004) 130-132
28. Guerra J.M., Wu J., Miller J.M., and Groh W.J. Increase in ventricular tachycardia frequency after biventricular implantable cardioverter defibrillator upgrade. J Cardiovasc Electrophysiol 14 (2003) 1245-1247
29. Di Cori A., Bongiorni M.G., Arena G., et al. New-onset ventricular tachycardia after cardiac resynchronization therapy. J Interv Card Electrophysiol 12 (2005) 231-235
30. Bradley D.J., Bradley E.A., Baughman K.L., et al. Cardiac resynchronization and death from progressive heart failure. a meta-analysis of randomized controlled trials. JAMA 289 (2003) 730-740
31. Reuter S., Garrigue S., Barold S.S., et al. Comparison of characteristics in responders versus nonresponders with biventricular pacing for drug-resistant congestive heart failure. Am J Cardiol 89 (2002) 346-350
32. Bax J.J., Marwick T.H., Molhoek S.G., et al. Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation. Am J Cardiol 92 (2003) 1238-1240
33. Kies P., Boersma E., Bax J.J., et al. Determinants of recurrent ventricular arrhythmia or death in 300 consecutive patients with ischemic heart disease who experienced aborted sudden death. data from the Leiden Out-of-Hospital Cardiac Arrest study. J Cardiovasc Electrophysiol 16 (2005) 1049-1056